All Kathrin de la Rosa articles
-
NewsSpike protein mutants with low binding affinity usher in new Covid vaccine
Researchers have succeeded in producing a new vaccine against the SARS-CoV-2 coronavirus by identifying spike protein mutants that lack binding affinity.
